Newest Issue is Out. Get your exclusive copy today.
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Sigilon Therapeutics Inc a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics platform announced that the United States Food and Drug Administration FDA has granted orphan drug d...
Dicerna Pharmaceuticals Inc a leading developer of investigational ribonucleic acid interference RNAi therapeutics announced that Roche has initiated RG in a Rochesponsored Phase combination trial for the treatment of chronic hepatitis B virus HBV i...
Enzyre which is developing breakthrough ambulant diagnostic technology for blood coagulation testing announced that it has entered into a strategic partnership with Takeda Pharmaceutical Company Limited Takeda to develop assays for the diagnosis and...
Sharp part of UDG Healthcare plc a global leader in contract packaging and clinical supply services has appointed Ria RhemrevBoom as its new lead EU Qualified Person QP for market release services In her new role Ria will take responsibility for lead...
Roche announced that the US Food and Drug Administration FDA approved ActemraRoActemra tocilizumab subcutaneous injection for slowing the rate of decline in pulmonary function in adult patients with systemic sclerosisassociated interstitial lung dise...
Kintor Pharmaceutical Limited is pleased to announce that the Investigational New Drug IND application of the phase III clinical trial of Proxalutamides treatment of male COVID outpatients has been approved by the United States Food and Drug Administ...
Kite a Gilead Company announced that the US Food and Drug Administration FDA has granted accelerated approval to Yescarta axicabtagene ciloleucel for the treatment of adult patients with relapsed or refractory follicular lymphoma FL after two or more...
ABclonal Biotechnology Co Ltd a global life science tools and services provider acquires Yurogen Biosystems LLC a contract research organization dedicated to monoclonal antibody discovery using singleBcellbased SMabTM platform
Elekta announced that its latest solution for proton therapy Monaco treatment planning for protons has received k clearance from the US Food and Drug Administration Monaco brings robust functionality for proton therapy
The US Food and Drug Administration FDA approved Pfizer Incs NYSE PFE supplemental New Drug Application sNDA for LORBRENA lorlatinib expanding the indication to include firstline treatment of people with anaplastic lymphoma kinase ALKpositive nonsmal...
EXIthera Pharmaceuticals a clinicalstage biotechnology company focused on addressing bleeding complications associated with currently available antithrombotic agents through the targeted inhibition of coagulation Factor XIa
Novartis announced today that it has signed an initial agreement to manufacture the mRNA and bulk drug product for the COVID vaccine candidate CVnCoV from CureVac to aid in the fight against the COVID pandemic
Gilead Sciences Inc today announced the completion of the previously announced transaction to acquire MYR GmbH for up to approximately billion in aggregate cash consideration The acquisition provides Gilead with Hepcludex bulevirtide which was condi...
Tirzepatide led to superior AC and body weight reductions from baseline across all three doses compared to injectable semaglutide mg in adults with type diabetes in Eli Lilly and Companys week SURPASS clinical trial In topline results from the larg...
Biogen Inctoday announced its plans to build a new gene therapy manufacturing facility at its Research Triangle Park RTP manufacturing campuses in North Carolina to support its growing gene therapy pipeline across multiple therapeutic areas
Foresee Pharmaceuticals announced today that it has entered into an exclusive license agreement with Intas Pharmaceuticals Intas for the US commercialization of Foresees novel FP program Leuprolide Mesylate Injectable Suspension LMIS readytouse subcu...
Aptamer Group the developer of Optimer reagents and therapeutics today announced the extension of their current agreement with AstraZeneca a global biopharmaceutical company This agreement will build upon the existing collaboration to evaluate the po...
Sorrento Therapeutics Inc announced that the FDA has cleared Sorrentos internally developed antiCD monoclonal antibody STI which was discovered from Sorrentos GMAB library for an initial clinical trial
Eyenovia Inc a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print MAP therapeutics today announced that the US Food and Drug Administration FDA has accepted the Companys New Drug Application NDA for Myd...
MedAlliance the first drugeluting balloon DEB company in the world to receive US Food and Drug Administration FDA Breakthrough Device Designation Status for a sirolimus DEB has now been awarded breakthrough status for SELUTION SLR
Corium Inc a commercialstage biopharmaceutical company leading the development and commercialization of novel central nervous system CNS therapies announced the US Food and Drug Administration FDA approval of oncedaily oral capsule AZSTARYSTM serdexm...
Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases
Shanghai Junshi Biosciences Co Ltd and Coherus Biosciences Incannounced the initiation of the rolling submission of the Biologics License Application BLA for toripalimab to the US Food and Drug Administration FDA for the treatment of recurrent or met...
ADMA Biologics Inc an endtoend commercial biopharmaceutical company dedicated to manufacturing marketing and developing specialty plasmaderived biologics today announced that its plasma collection center located in Kennesaw
Partner Therapeutics Inc PTx a commercial biotech company announces a licensing and collaboration agreement with Munichbased SIRS Therapeutics and Viennabased F Pharma to support the development of FX a synthetic peptide that has a broad spectrum of...
Sterile and contained pharmaceutical product transfer specialist ChargePoint Technology ChargePoint or the Company has today announced that it has been acquired by Arcline Investment Management Arcline The deal will see ChargePoint Technology headqua...
Flexion Therapeutics Inc announced the US Food and Drug Administration FDA cleared the Investigational New Drug IND application for FX a locally administered NaV inhibitor known as funapide formulated for extendedrelease in a thermosensitive hydrogel
Eisai Co Ltd announced that its Hong Kong subsidiary Eisai Hong Kong Co Ltd has obtained approval for the inhousediscovered and developed orexin receptor antagonist DAYVIGO generic name lemborexant for the treatment of adults with insomnia characteri...
After more than registrations for our first live seminar from the series Riots under vacuum we warmly invite you to our next seminar On the March our process engineer Dr HansJoachim Jacob will talk on the subject of Riots under vacuum ContiTDS in P...
KemPharm Inc a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs today announced that the US Food and Drug Administration FDA has approved the New Drug Application for NDA AZSTARYS formerly referred to...
